Rare diseases
Investigational molecules
Locations
Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine
PolandStudy of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
PolandStudy of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
PolandStudy Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma
PolandStudy on Apalutamide and Drug Combination for Patients with Metastatic Castration-Sensitive Prostate Cancer
PolandStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
PolandStudy Comparing MK-7684A with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
PolandStudy of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer
PolandStudy on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease
PolandStudy of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer
PolandStudy on Nipocalimab and Certolizumab for Patients with Active Rheumatoid Arthritis After Advanced Therapy
PolandStudy on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
